Laboratorio Reig Jofre, S.A. (FRA:FEQ1)

Market Cap	201.09M -4.9%
Revenue (ttm)	336.68M -1.4%
Net Income	5.02M -51.6%
EPS	0.06 -53.0%
Shares Out	n/a
PE Ratio	40.05
Forward PE	33.51
Dividend	0.04 (1.62%)
Ex-Dividend Date	May 15, 2025

Volume	n/a
Average Volume	402
Open	2.420
Previous Close	2.420
Day's Range	2.410 - 2.420
52-Week Range	2.130 - 3.250
Beta	n/a
RSI	47.40
Earnings Date	May 7, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,512
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FEQ1

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.